AQUALUNG THERAPEUTICS, CORP STTR Phase II Award, September 2023
A STTR Phase II contract was awarded to Aqualung Therapeutics in September, 2023 for $809,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.